✦ LIBER ✦

29 Results of independent review of 374 patients with non-small cell lung cancer (NSCLC) treated with gemcitabine (Gemzar®)

✍ Scribed by Gwyther, S.J.; Aapro, M.S.; Hatty, S.R.; Postmus, P.E.; Smith, I.E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of phase II studies of gemcitabi

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

99 Efficacy and toxicity profile of gemc

✍ Guerra, J.A.; Lianes, P.; Paz-Ares, L.; Castellano, D.; Gómez-Martín, C.; Cortés 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 149 KB

A review of etoposide in patients with n

✍ Itri, L.M.; Gralla, R.J. 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 398 KB

PP43. Quality of life assessments of pat

✍ A Anton; A Carrato; JL Gonzalez-Larriba; C Vadel; B Masutti; J Montalar; E Arand 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

1088 Non-small-cell lung cancer (NSCLC)

✍ Mira Flores, M.; Morales Murillo, S.; Garcia Alonso, E.; Balil Gilart, A.; Carce 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Evaluation of pulmonary function tests i

✍ Nackaerts, K; Lievens, Y; Vandenheuvel, M; Vansteenkiste, J; Vanhees, S; Verlede 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 109 KB